NCT04628221View on ClinicalTrials.gov

Open Label Study Using OsteoProbe System

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 30, 2020

Conditions
Adverse Effects in the Use of the OsteoProbe System
Interventions
DEVICE

OsteoProbe System

"The OsteoProbe® System (OsteoProbe) is a bone microindentation measurement tool. The device is a measurement tool that is not intended to make a diagnosis or provide a treatment decision. There are no other available measurement tools for clinical assessment of bone's resistance to microindentation."

Trial Locations (1)

68134

Meridian Clinical Research, LLC., Omaha

Sponsors
All Listed Sponsors
collaborator

MCRA

INDUSTRY

lead

Active Life Scientific, Inc.

INDUSTRY

NCT04628221 - Open Label Study Using OsteoProbe System | Biotech Hunter | Biotech Hunter